Back
  1. Home
  2. Profile of Francois PAQUOT (ULiège)
Profil

PAQUOT Francois

Département de médecine interne > Service de néphrologie

See author's contact details
Main Referenced Co-authors
Jouret, François  (6)
Cavalier, Etienne  (4)
Delanaye, Pierre  (4)
Krzesinski, Jean-Marie  (4)
Bouquegneau, Antoine  (3)
Main Referenced Keywords
chronic kidney disease (2); sclerostin (2); Acute kidney dysfunction with no rejection (ADNR) (1); Acute Kidney Injury (1); acute kidney injury (1);
Main Referenced Disciplines
Urology & nephrology (10)
Laboratory medicine & medical technology (4)

Publications (total 10)

The most downloaded
487 downloads
Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7 https://hdl.handle.net/2268/181651

The most cited

26 citations (Scopus®)

Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7 https://hdl.handle.net/2268/181651

PAQUOT, F., & Jouret, F. (September 2023). Vignette diagnostique de l’étudiant. Approche diagnostique de la rhabdomyolyse. Revue Médicale de Liège, 78 (9), 529 - 532.
Editorial Reviewed verified by ORBi

PAQUOT, F., WEEKERS, L., BONVOISIN, C., Pottel, H., & Jouret, F. (01 July 2019). "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation. BMC Nephrology, 20 (1), 249. doi:10.1186/s12882-019-1444-5
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008
Peer Reviewed verified by ORBi

PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003
Peer Reviewed verified by ORBi

DELANAYE, P., PAQUOT, F., BOUQUEGNEAU, A., Blocki, F., Krzesinski, J.-M., Evenepoel, P., Pottel, H., & Cavalier, E. (2018). Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrology Dialysis Transplantation, 33 (8), 1404-1410. doi:10.1093/ndt/gfx282
Peer Reviewed verified by ORBi

PAQUOT, F., & Krzesinski, J.-M. (2017). Inhibiteurs de la pompe à protons et risque d'insuffisance rénale. Revue Médicale Suisse.
Peer Reviewed verified by ORBi

PAQUOT, F., Pottel, H., BONVOISIN, C., WEEKERS, L., & JOURET, F. (2017). "Acute kidney dysfunction with no rejection (ADNR)" is associated with poor outcomes in kidney transplant recipients. Transplant International, 30 ((Suppl. 2)), 558.
Peer Reviewed verified by ORBi

Paquot, F., HUART, J., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2017). Implications of the calcium-sensing receptor in ischemia/reperfusion. Acta Cardiologica, 72 (2), 125-131. doi:10.1080/00015385.2017.1291136
Peer Reviewed verified by ORBi

PAQUOT, F., BOUQUEGNEAU, A., CAVALIER, E., & DELANAYE, P. (2016). Sclérostine & insuffisance rénale: que nous apprennent les différents méthodes de dosage? Néphrologie et Thérapeutique, 12 (5), 374.
Peer Reviewed verified by ORBi

Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7
Peer Reviewed verified by ORBi

Contact ORBi